These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10945088)

  • 1. Critical approach to antidepressant trials. Blindness protection is necessary, feasible and measurable.
    Even C; Siobud-Dorocant E; Dardennes RM
    Br J Psychiatry; 2000 Jul; 177():47-51. PubMed ID: 10945088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placebo-controlled studies in depression: necessary, ethical and feasible.
    Baldwin D; Broich K; Fritze J; Kasper S; Westenberg H; Möller HJ
    Eur Arch Psychiatry Clin Neurosci; 2003 Feb; 253(1):22-8. PubMed ID: 12664309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Innovation and placebos in research: a new design of clinical trial.
    Holbrook A; Goldsmith C
    Lancet; 2003 Dec; 362(9401):2036-7. PubMed ID: 14697799
    [No Abstract]   [Full Text] [Related]  

  • 4. Side effects and the "blindability" of clinical drug trials.
    White K; Kando J; Park T; Waternaux C; Brown WA
    Am J Psychiatry; 1992 Dec; 149(12):1730-1. PubMed ID: 1443253
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does differential drop-out explain the influence of study design on antidepressant response? A meta-analysis.
    Rutherford BR; Sneed JR; Roose SP
    J Affect Disord; 2012 Sep; 140(1):57-65. PubMed ID: 22387053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of antidepressant trials using active and inert placebos.
    Moncrieff J
    Int J Methods Psychiatr Res; 2003; 12(3):117-27. PubMed ID: 12953139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluvoxamine: a review of the controlled trials in depression.
    Ware MR
    J Clin Psychiatry; 1997; 58 Suppl 5():15-23. PubMed ID: 9184623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trials.
    Khan A; Brodhead AE; Kolts RL; Brown WA
    J Psychiatr Res; 2005 Mar; 39(2):145-50. PubMed ID: 15589562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mousetrap: managing the placebo effect in antidepressant trials.
    Lakoff A
    Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
    [No Abstract]   [Full Text] [Related]  

  • 10. Considering the case for an antidepressant drug trial involving temporary deception: a qualitative enquiry of potential participants.
    Dowrick CF; Hughes JG; Hiscock JJ; Wigglesworth M; Walley TJ
    BMC Health Serv Res; 2007 Apr; 7():64. PubMed ID: 17470280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of antidepressant placebo-controlled trials for geriatric depression: limitations of current data and directions for the future.
    Taylor WD; Doraiswamy PM
    Neuropsychopharmacology; 2004 Dec; 29(12):2285-99. PubMed ID: 15340391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is loss of antidepressant effect during continuation therapy related to placebo effect?
    Harrison W; Stewart JW; McGrath PJ; Tricamo E; Quitkin FM
    Psychopharmacol Bull; 1988; 24(1):9-13. PubMed ID: 3290953
    [No Abstract]   [Full Text] [Related]  

  • 13. Placebo response and antidepressant clinical trial outcome.
    Khan A; Detke M; Khan SR; Mallinckrodt C
    J Nerv Ment Dis; 2003 Apr; 191(4):211-8. PubMed ID: 12695731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Placebo-controlled antidepressant drug trials. Considering the ethical implications].
    Deisenhammer EA; Hinterhuber H
    Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are placebo controls necessary to test new antidepressants and anxiolytics?
    Khan A; Khan S; Brown WA
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):193-7. PubMed ID: 12366872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of placebo-controlled trials with bupropion.
    Zung WW
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):104-14. PubMed ID: 6406436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is there a placebo problem in antidepressant trials?
    Yang H; Cusin C; Fava M
    Curr Top Med Chem; 2005; 5(11):1077-86. PubMed ID: 16181132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant drug therapy for bulimia: current status.
    Pope HG; Hudson JI
    J Clin Psychiatry; 1986 Jul; 47(7):339-45. PubMed ID: 3087968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nefazodone: aspects of efficacy.
    Rickels K; Robinson DS; Schweizer E; Marcus RN; Roberts DL
    J Clin Psychiatry; 1995; 56 Suppl 6():43-6. PubMed ID: 7649973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methodology of measuring the efficacy of antidepressants--European viewpoint.
    Woggon B
    Psychopharmacology (Berl); 1992; 106 Suppl():S90-2. PubMed ID: 1546151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.